Massive Bio
Developer of an artificial intelligence-driven platform intended to connect cancer patients to biopharmaceutical clinical trials.
Why it ranks
How the rank works- went through 500 GlobalProgram · this site+2
A sum of public facts, not a judgement and not investment advice.
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Active | YCW25 | |
| Vine HealthShared: cancer patient, healthcareEF 2019Not statedOther | Other | Not stated | EF2019 |
| AI | Not stated | Plug and Play | |
| Other | Not stated | EF2019 | |
| AI | Active | YCW23 | |
| Other | Elsewhere |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Not stated | Antler2026 | |
| AI | Not stated | EF2025 | |
| Other | Not stated | EF2019 | |
| Other | Not stated | 500 GlobalGA 18 | |
| Other | Not stated | SPC2021 |
Also from 500 Global in AI
All of 500 GlobalPrograms
| Program | Cohort | Source |
|---|---|---|
| 2016 | 500 Global Page |
About Massive Bio
Developer of an artificial intelligence-driven platform intended to connect cancer patients to biopharmaceutical clinical trials. The company offers tech-enabled services and a big data platform that addresses the clinical trial enrollment value chain by providing patient identification, pre-screening, and concierge enrollment enablement while being focused on oncology and innovative data, technology, and services, enabling patients to get an effective treatment without disrupting lives and becoming a financial hindrance.
- Category
- AI
- Location
- United States
- Checked
- 7h ago
Tags: Health Tech, Healthcare
Massive Bio: questions
Which accelerators did Massive Bio go through?
Massive Bio is listed by 500 Global (Global 2016).
Where is Massive Bio based?
Massive Bio lists United States as its location on 500 Global's page.